Treatment of Brain Edema and Herniation Secondary to Ischemic or Hemorrhagic Stroke
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2015
Price : $35 *
At a glance
- Drugs Conivaptan (Primary) ; Mannitol; Sodium chloride
- Indications Brain oedema; Stroke complications
- Focus Therapeutic Use
- 16 Sep 2015 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
- 16 Mar 2015 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 08 May 2014 Planned End Date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.